Streamlined clinical trials regulations will boost pharmaceutical investment in Taiwan

Taiwan |  Opinion | By BioSpectrum Bureau  | 0 Comment | 11 Oct, 2015

Singapore: Taiwan will remain a key destination for clinical trials due to the government's efforts to augment the country's medical infrastructure and streamline clinical research regulato...Read more

Taiwan market forecast

Taiwan |  Opinion | By BioSpectrum Bureau  | 0 Comment | 19 Jan, 2016

Singapore: Pricing and reimbursement will remain a challenge for pharmaceutical firms operating in Taiwan. The turnaround of the National Health Insurance'sbudget from a deficit to a surplu...Read more

Bayer HealthCare clocks 14.9% rise in APAC Pharma biz

Taiwan |  News | By BioSpectrum Bureau  | 0 Comment | 25 Mar, 2014

Singapore: Bayer HealthCare has recorded sales hike of 14.9 percent to USD 4171 million (EUR 3016 million) in 2013 for its pharmaceuticals division in the Asia Pacific region. "We are happ...Read more

SHL invests $40 mn in production facilities

Taiwan |  News | By BioSpectrum Bureau  | 0 Comment | 22 Feb, 2013

Singapore: Taiwan-based drug delivery firm, SHL is planning to expand its production facilities with an investment of $40 million. SHL will invest primarily in molding, material handling, ...Read more

PharmaEngine files NDA for metastatic cancer drug

Taiwan |  News | By BioSpectrum Bureau  | 0 Comment | 02 Jun, 2015

Singapore: Taiwan's PharmaEngine has filed a New Drug Application (NDA) to the Taiwan Food and Drug Administration (TFDA) for MM-398 (irinotecan liposome injection, also known as nal-IRI) i...Read more

PharmaEngine gets TFDA nod for pancreatic cancer drug

Taiwan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 07 Mar, 2016

Singapore: Taiwan based PharmaEngine has recieved Taiwan Food and Drug Administration (TFDA) approval of the product license of ONIVYDE (irinotecan liposome injection, nal-IRI). ONIVYDE is...Read more

Taiwan on high alert as MERS spreads in Asia

Taiwan |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jun, 2015

Singapore: In a bid to prevent the deadly MERS virus from entering its borders, the Taipei Public Health Department (TPHD) has issued guidance to the management of 488 hotel and concert ven...Read more

QPS to deploy preclinical data management system, Pristima Suite

Taiwan |  News | By BioSpectrum Bureau  | 0 Comment | 03 Oct, 2012

Singapore: QPS Taiwan, a global preclinical toxicology services provider, has been selected to deploy Pristima Suite, which is Xybion's premier preclinical application. QPS will leverage P...Read more

TWi's drug gets rare disease drug designation in Taiwan

Taiwan |  News | By BioSpectrum Bureau  | 0 Comment | 11 Mar, 2015

Singapore: Taiwan based TWi Pharmaceutical's drug candidate AC-203 has received designation of rare disease drug by Taiwan FDA to treat Epidermolysis Bullosa Simplex (EBS), and is eligible ...Read more

Taiwan, US univ implant heart pump on baby cow

Taiwan |  News | By BioSpectrum Bureau  | 0 Comment | 30 Oct, 2013

Singapore: The Heart Science and Medical Devices Research Center, National Cheng Kung University, Taiwan (NCKU HSDMRC), and the division of cardiothoracic surgery, department of surgery, D...Read more

Sale of wound care devices spurs in Asia-Pacific: Frost & Sullivan analysis report

Taiwan |  News | By BioSpectrum Bureau  | 0 Comment | 04 Sep, 2013

Singapore: Advanced wound care and modern wound closure products are gaining an edge over traditional wound dressings in Asia Pacific as lower bed capacity in hospitals and the trend toward...Read more

TaiGen initiates clinical trial of leukemia drug in China

Taiwan |  News | By BioSpectrum Bureau  | 0 Comment | 04 May, 2015

Singapore: Taiwan's TaiGen Biotechnology has initiated first burixafor trial for relapsed or refractory acute myeloid leukemia in China. Burixafor is being studied in combination with two ...Read more

ScinoPharm, Foresee form joint venture

Taiwan |  News | By BioSpectrum Bureau  | 0 Comment | 01 Feb, 2013

Singapore: Taiwanese company ScinoPharm and US-based Foresee Pharmaceuticals have signed an investment agreement to form a joint venture. This venture will develop a series of peptide injec...Read more

Genovate biotech to invest $1bn in China

Taiwan |  News | By BioSpectrum Bureau  | 0 Comment | 28 Sep, 2015

Singapore: Genovate Biotechnology, Taiwan based pharmaceutical company, has started the construction of phase I of its Insulin Ecological Industrial Park in Changzhou National Hi-tech Distr...Read more

Asia's largest medicare show opens in Taipei

Taiwan |  News | By Nandita Singh | 0 Comment | 14 Jun, 2012

Taipei: Asia's largest medicare show opened in Taipei, Taiwan, with a crisp opening ceremony showcasing nine of the indigenously developed products selected from a shortlist of 56 made-in-T...Read more

Taiwan firm develops nano-medication to inhibit HIV replication

Taiwan |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jul, 2015

Singapore: Lorati, a Taiwan-based biotechnology and skincare company, has developed nano-medication to inhibit HIV-1 viral replication. Mr David Lo, CEO, Lorati commented, "nano-medication...Read more

New breakthrough in dementia research

Taiwan |  News | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2014

Singapore: Researchers at the Taipei-based Academia Sinica announced that they have discovered a new molecule that aids in screening, early detection of dementia and other diseases caused b...Read more

Vaccine of the future: Virus-like particles to trigger body's defence

Taiwan |  Analysis | By BioSpectrum Bureau  | 0 Comment | 11 Jul, 2012

Virus-like particles (VLPs) are among the most exciting emerging vaccine technologies for generating effective and long-lasting protection. It is an advanced technology that has a number of...Read more